Skip to main content
DexcomRevenue

Dexcom Reports Second Quarter 2026 Financial Results

What happened

DexCom reported worldwide revenue of $1.308 billion for the second quarter of 2026, a 13% increase from the same period in 2025.

Source

Article excerpt

Highlighted: the sentence this signal was extracted from

DexCom, Inc. (Nasdaq: DXCM) today reported its financial results as of and for the quarter ended June 30, 2026. Second Quarter 2026 Financial Highlights: Second Quarter 2026 Strategic Highlights: "During the quarter, we had the opportunity to host many of you at our 2026 Investor Day, where we highlighted our substantial market opportunity and introduced a new long-term financial outlook through 2030," said Jake Leach, Dexcom's president and CEO. "This quarter's performance and the successful outcomes from our CONNECT trial reinforce our confidence in the path ahead and position us well to deliver on our long-range plan." 2026 Annual Guidance Dexcom is raising the midpoint of fiscal year 2026 Revenue guidance and increasing fiscal year 2026 guidance for Non-GAAP Gross Profit Margin, Non-GAAP Operating Margin, and Adjusted EBITDA Margin to the following levels: ____________________ Second Quarter 2026 Financial Results Revenue: In the second quarter of 2026, worldwide revenue grew 13% to $1.308 billion on a reported basis, up from $1.157 billion in the second quarter of 2025. Gross Profit: GAAP gross profit totaled $830.0 million or 63.4% of revenue for the second quarter of 2026, compared to $688.8 million or 59.5% of revenue in the second quarter of 2025. Non-GAAP gross profit* totaled $838.5 million or 64.1% of reported revenue for the second quarter of 2026, compared to...

Keep reading with a free account

The rest of this article, and every signal for Dexcom, is in your free account.

Extracted by Autobound

From the Signal API record
Event
Revenue

What this signalsRevenue results often set the next budget cycle.

Takes effect
Jun 30, 2026

More revenue signals at other companies

The full record

From the Signal API record

Numbers

Amount (USD)
$1.3T

Extraction

Confidence
95%
Detected
Jul 30, 2026
signal_type
news
signal_subtype
has_revenue

Use this data

Get every revenue signal for Dexcom and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Dexcom this week?”

  2. Send it to your own tools

    The Signal API returns revenue signals for any list of companies as JSON, for your CRM, warehouse or app.

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full news record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Show the full JSONThe record on this page and the API request

GET /v1/signals/2a37b260-47aa-c17c-fca9-5ba43126ecfd returns this record as JSON. POST /v1/companies/enrich returns every signal for dexcom.com.

{
  "signal_id": "2a37b260-47aa-c17c-fca9-5ba43126ecfd",
  "signal_type": "news",
  "signal_subtype": "has_revenue",
  "detected_at": "2026-07-30T20:02:00+00:00",
  "company": {
    "name": "Dexcom",
    "domain": "dexcom.com"
  },
  "data": {
    "url": "https://www.financialcontent.com/article/bizwire-2026-7-30-dexcom-reports-second-quarter-2026-financial-results",
    "title": "Dexcom Reports Second Quarter 2026 Financial Results - FinancialContent",
    "excerpt": "DexCom, Inc. (Nasdaq: DXCM) today reported its financial results as of and for the quarter ended June 30, 2026. Second Quarter 2026 Financial Highlights: Second Quarter 2026 Strategic Highlights: “During the quarter, we had the opportunity to host many of you at our 2026 Investor Day, where we highlighted our substantial market opportunity and introduced a new long-term financial outlook through 2030,” said Jake Leach, Dexcom’s president and CEO. “This quarter’s performance and the successful outcomes from our CONNECT trial reinforce our confidence in the path ahead and position us well to deliver on our long-range plan.” 2026 Annual Guidance Dexcom is raising the midpoint of fiscal year 2026 Revenue guidance and increasing fiscal year 2026 guidance for Non-GAAP Gross Profit Margin, Non-GAAP Operating Margin, and Adjusted EBITDA Margin to the following levels: ____________________ Second Quarter 2026 Financial Results Revenue: In the second quarter of 2026, worldwide revenue grew 13% to $1.308 billion on a reported basis, up from $1.157 billion in the second quarter of 2025. Gross Profit: GAAP gross profit totaled $830.0 million or 63.4% of revenue for the second quarter of 2026, compared to $688.8 million or 59.5% of revenue in the second quarter of 2025. Non-GAAP gross profit* totaled $838.5 million or 64.1% of reported revenue for the second quarter of 2026, compared to...",
    "summary": "DexCom reported worldwide revenue of $1.308 billion for the second quarter of 2026, a 13% increase from the same period in 2025.",
    "planning": false,
    "confidence": 0.95,
    "published_at": "2026-07-30T20:02:00Z",
    "effective_date": "2026-06-30",
    "article_sentence": "In the second quarter of 2026, worldwide revenue grew 13% to $1.308 billion on a reported basis, up from $1.157 billion in the second quarter of 2025.",
    "amount_normalized": 1308000000000
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.